Replies to post #42003 on Humanigen Inc (HGENQ)

[cowtown jay]

Hello, InfinitePhoenix4. Welcome to the room, and thank you for posting your first Ihub message here. I appreciate the thought you put into it.

I think it is very likely that lenz could receive it's first regulatory approval in Australia, to treat CMML. It's also possible that a Priority Review Voucher in the range of ~$100M could be awarded with that approval.

But Taran didn't buy Humanigen. Taran bought the intellectual property rights. Do you agree, because I don't think you do? Let's start there, if you want.

https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1061258&projectCode=HUM&docketNumber=155&source=DM

I haven't given the document the full study it deserves, because I have total confidence in management. I am as confident in Dale's stewardship of Humanigen's shares, as I am in Durrant's purchase of the intellectual property rights. Besides, I think we will see a merger, anyway. So I don't foresee value being left behind, once the share structure and the intellectual property rights are rejoined (joined), by some means.

I hope this all becomes moot, but even more so, I also hope to see the recall of the loaned shares, in short order. But I do agree that our value lies in the intellectual property, and have said that, "To be honest, I think it would take a lot more study for me to feel that I have confidence in making a deduction about HOW these guys have navigated during this bankruptcy." I'm looking forward to the completion of our restructuring.